CA1326017C - Ribofuranuronic acid derivatives - Google Patents
Ribofuranuronic acid derivativesInfo
- Publication number
- CA1326017C CA1326017C CA000563261A CA563261A CA1326017C CA 1326017 C CA1326017 C CA 1326017C CA 000563261 A CA000563261 A CA 000563261A CA 563261 A CA563261 A CA 563261A CA 1326017 C CA1326017 C CA 1326017C
- Authority
- CA
- Canada
- Prior art keywords
- desoxy
- purinyl
- beta
- methyl
- ribofuranuronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3711562 | 1987-04-06 | ||
| DEP3711561.8 | 1987-04-06 | ||
| DE3711563 | 1987-04-06 | ||
| DEP3711564.2 | 1987-04-06 | ||
| DEP3711563.4 | 1987-04-06 | ||
| DE3711561 | 1987-04-06 | ||
| DE3711564 | 1987-04-06 | ||
| DEP3711562.6 | 1987-04-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1326017C true CA1326017C (en) | 1994-01-11 |
Family
ID=27433888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000563261A Expired - Fee Related CA1326017C (en) | 1987-04-06 | 1988-04-05 | Ribofuranuronic acid derivatives |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS63258892A (pm) |
| KR (1) | KR880012629A (pm) |
| AT (1) | AT393507B (pm) |
| AU (1) | AU609109B2 (pm) |
| BE (1) | BE1002151A5 (pm) |
| CA (1) | CA1326017C (pm) |
| CH (1) | CH676121A5 (pm) |
| DK (1) | DK183488A (pm) |
| ES (1) | ES2007177A6 (pm) |
| FI (1) | FI87463C (pm) |
| FR (1) | FR2613367A1 (pm) |
| GB (1) | GB2203149B (pm) |
| HU (1) | HU201955B (pm) |
| IL (1) | IL85969A (pm) |
| IT (1) | IT1219892B (pm) |
| LU (1) | LU87181A1 (pm) |
| MY (1) | MY102323A (pm) |
| NL (1) | NL8800862A (pm) |
| NZ (1) | NZ224131A (pm) |
| PH (1) | PH25424A (pm) |
| PT (1) | PT87153B (pm) |
| SE (1) | SE8801236A0 (pm) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4755594A (en) * | 1986-01-31 | 1988-07-05 | Warner-Lambert Company | N6 -substituted adenosines |
| US5063233A (en) * | 1986-11-14 | 1991-11-05 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists |
| US4954504A (en) * | 1986-11-14 | 1990-09-04 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity |
| NL8702926A (nl) * | 1986-12-15 | 1988-07-01 | Sandoz Ag | Nieuwe furanuronzuurderivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. |
| US4968697A (en) * | 1987-02-04 | 1990-11-06 | Ciba-Geigy Corporation | 2-substituted adenosine 5'-carboxamides as antihypertensive agents |
| EP0277917A3 (en) * | 1987-02-04 | 1990-03-28 | Ciba-Geigy Ag | Certain adenosine 5'-carboxamide derivatives |
| US5140015A (en) * | 1990-02-20 | 1992-08-18 | Whitby Research, Inc. | 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| USRE36494E (en) * | 1990-02-20 | 2000-01-11 | Discovery Therapeutics, Inc. | 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| IT1254915B (it) * | 1992-04-24 | 1995-10-11 | Gloria Cristalli | Derivati di adenosina ad attivita' a2 agonista |
| GB9301000D0 (en) * | 1993-01-20 | 1993-03-10 | Glaxo Group Ltd | Chemical compounds |
| TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
| KR20010071591A (ko) | 1998-06-23 | 2001-07-28 | 그레이엄 브레레톤, 레슬리 에드워즈 | 2-(퓨린-9-일)-테트라히드로푸란-3,4-디올 유도체 |
| AR023463A1 (es) | 1999-04-16 | 2002-09-04 | Schering Corp | Uso de compuestos de azetidinona |
| US20050033044A1 (en) | 2003-05-19 | 2005-02-10 | Bristol-Myers Squibb Pharma Company | Methods for preparing 2-alkynyladenosine derivatives |
| AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
| JP5011112B2 (ja) * | 2004-09-20 | 2012-08-29 | イノテック ファーマシューティカルズ コーポレイション | プリン誘導体を含有する炎症性疾患の治療用医薬 |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH606084A5 (en) * | 1975-02-18 | 1978-10-13 | Hoffmann La Roche | (Di) nitrates of adenosine -5'-carboxylic acid derivs |
| US4167565A (en) * | 1976-11-08 | 1979-09-11 | Abbott Laboratories | Adenosine-5'-carboxamides and method of use |
| DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
| NL8702926A (nl) * | 1986-12-15 | 1988-07-01 | Sandoz Ag | Nieuwe furanuronzuurderivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. |
| EP0277917A3 (en) * | 1987-02-04 | 1990-03-28 | Ciba-Geigy Ag | Certain adenosine 5'-carboxamide derivatives |
-
1988
- 1988-03-28 LU LU87181A patent/LU87181A1/fr unknown
- 1988-03-30 IT IT47794/88A patent/IT1219892B/it active
- 1988-03-30 BE BE8800374A patent/BE1002151A5/fr not_active IP Right Cessation
- 1988-03-30 FR FR8804356A patent/FR2613367A1/fr not_active Withdrawn
- 1988-03-31 CH CH1228/88A patent/CH676121A5/de not_active IP Right Cessation
- 1988-03-31 GB GB8807750A patent/GB2203149B/en not_active Expired - Lifetime
- 1988-04-04 KR KR1019880003819A patent/KR880012629A/ko not_active Ceased
- 1988-04-04 PT PT87153A patent/PT87153B/pt active IP Right Grant
- 1988-04-04 IL IL85969A patent/IL85969A/xx not_active IP Right Cessation
- 1988-04-04 PH PH36731A patent/PH25424A/en unknown
- 1988-04-04 MY MYPI88000344A patent/MY102323A/en unknown
- 1988-04-05 AU AU14151/88A patent/AU609109B2/en not_active Ceased
- 1988-04-05 CA CA000563261A patent/CA1326017C/en not_active Expired - Fee Related
- 1988-04-05 JP JP63084974A patent/JPS63258892A/ja active Pending
- 1988-04-05 FI FI881571A patent/FI87463C/fi not_active IP Right Cessation
- 1988-04-05 HU HU881638A patent/HU201955B/hu not_active IP Right Cessation
- 1988-04-05 SE SE8801236A patent/SE8801236A0/sv unknown
- 1988-04-05 AT AT873/88A patent/AT393507B/de not_active IP Right Cessation
- 1988-04-05 ES ES8801031A patent/ES2007177A6/es not_active Expired
- 1988-04-05 NL NL8800862A patent/NL8800862A/nl not_active Application Discontinuation
- 1988-04-05 DK DK183488A patent/DK183488A/da not_active Application Discontinuation
- 1988-04-06 NZ NZ224131A patent/NZ224131A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT87153B (pt) | 1992-07-31 |
| GB8807750D0 (en) | 1988-05-05 |
| ES2007177A6 (es) | 1989-06-01 |
| SE8801236L (sv) | 1988-10-17 |
| LU87181A1 (fr) | 1988-11-17 |
| CH676121A5 (pm) | 1990-12-14 |
| FR2613367A1 (fr) | 1988-10-07 |
| KR880012629A (ko) | 1988-11-28 |
| ATA87388A (de) | 1991-04-15 |
| DK183488A (da) | 1988-10-07 |
| MY102323A (en) | 1992-05-28 |
| FI87463B (fi) | 1992-09-30 |
| NL8800862A (nl) | 1988-11-01 |
| DK183488D0 (da) | 1988-04-05 |
| IL85969A (en) | 1992-03-29 |
| AU1415188A (en) | 1988-10-06 |
| FI881571L (fi) | 1988-10-07 |
| SE8801236A0 (sv) | 1988-10-17 |
| JPS63258892A (ja) | 1988-10-26 |
| IT1219892B (it) | 1990-05-24 |
| IL85969A0 (en) | 1988-09-30 |
| AU609109B2 (en) | 1991-04-26 |
| AT393507B (de) | 1991-11-11 |
| FI881571A0 (fi) | 1988-04-05 |
| GB2203149A (en) | 1988-10-12 |
| BE1002151A5 (fr) | 1990-08-07 |
| NZ224131A (en) | 1991-12-23 |
| FI87463C (fi) | 1993-01-11 |
| HUT48902A (en) | 1989-07-28 |
| GB2203149B (en) | 1991-02-13 |
| IT8847794A0 (it) | 1988-03-30 |
| SE8801236D0 (sv) | 1988-04-05 |
| PT87153A (pt) | 1988-05-01 |
| HU201955B (en) | 1991-01-28 |
| PH25424A (pm) | 1991-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1326017C (en) | Ribofuranuronic acid derivatives | |
| US5219840A (en) | Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives | |
| US5464826A (en) | Method of treating tumors in mammals with 2',2'-difluoronucleosides | |
| CA1287349C (en) | Rebeccamycin analogs | |
| AU602909B2 (en) | Pyrimidine derivatives | |
| JPH052671B2 (pm) | ||
| EP0291917B1 (en) | Novel oxetanocins | |
| US5384310A (en) | 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions | |
| HK35597A (en) | New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs | |
| US20080300399A1 (en) | Processes related to making capecitabine | |
| EP0196618B1 (en) | 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments | |
| CA1291752C (en) | Furanuronic acid derivatives, process for their production and their use | |
| AU590409B2 (en) | Aminoglycoside steroids | |
| US5534503A (en) | 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses | |
| IE60470B1 (en) | Pyrimidine derivatives, a process for their manufacture and medicaments containing said derivatives | |
| WO2006122207A1 (en) | 6-hydrazinopurine 2'-methyl ribonucleosides and nucleotides for treatment of hcv | |
| JPH0633263B2 (ja) | 7−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤 | |
| US5214048A (en) | Oxetanocins | |
| HU203553B (en) | New process for producing oxetanocin g | |
| EP0135271A1 (en) | Spectinomycin analogues and their preparation | |
| CA2069714A1 (en) | Preparation of 6-0-acylelsamicin a derivatives | |
| WO1987004167A1 (en) | Aminoglycoside steroids, a process for their preparation, their use and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |